About icatibant
Bradykinin B2 receptor antagonist
Used for
- Treats acute attacks of hereditary angioedema in adults and adolescents aged 2 years and older.
Usual adult dose
30 mg injected under the skin; repeat every 6 hours if needed, up to 3 doses in 24 hours.
Usual dose in children
Dose is based on body weight: 10–30 mg injected under the skin, as directed by a clinician.
Common side effects
- Injection-site redness, swelling, pain, itching, or bruising
- Fever, dizziness, or headache
- Rash or nausea
Important warnings
- Seek emergency care for throat swelling or breathing difficulty; treatment may not prevent worsening.
- Use caution with acute heart or brain blood-vessel problems; bradykinin may affect blood pressure.
- For hereditary angioedema attacks only; it does not prevent future attacks.
Pregnancy
Human pregnancy information is limited; use only when clearly needed after clinical assessment.
Breastfeeding
It is unknown whether icatibant passes into breast milk; clinical advice is needed.
Interactions
- No important interactions are established; tell clinicians about all medicines being used.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.